Seelos Therapeutics Inc (SEEL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SEEL? Forum Prognose Aktiensplit

Finanzdaten der Seelos Therapeutics Inc-Aktie (SEEL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	11.33% 0.579	0.653	0.406	0.336	0.808
Operating Expenses	23.43% 6.634	8.664	13.01	11.29	9.74
Interest Income/Expense	21.05% 0.023	0.019	0.042	0.007	0.007
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	23.43% 6.634	8.664	13.01	11.29	9.74
Operating Income/Loss	24.42% -6.055	-8.011	-12.60	-10.95	-8.932
Nonoperating Income/Loss	32.56% 3.391	2.558	23.10	-18.54	-4.499
Income/Loss From Continuing Operations Before Tax	11.33% 0.579	0.653	0.406	10.50	0.808
Income/Loss From Continuing Operations After Tax	51.15% -2.664	-5.453	10.50	10.50	-13.43
Net Income/Loss	51.15% -2.664	-5.453	10.50	10.50	-13.43
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	110.68% 13.01	-121.77	135.33	131.92	112.52
Diluted Average Shares	110.68% 13.01	-121.77	148.14	131.92	112.52
Basic Earnings Per Share	97.32% -0.20	-7.47	0.08	-0.22	-0.12
Diluted Earnings Per Share	97.32% -0.20	-7.47	-0.12	-0.22	-0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | Open in MarketWatch | Open in Reuters